Dusseldorf - Delayed Quote EUR
Trulieve Cannabis Corp (T0A.DU)
4.0960
+0.2020
+(5.19%)
At close: May 16 at 7:32:00 PM GMT+2
Loading Chart for T0A.DU
- Previous Close
3.8940 - Open
4.0700 - Bid 3.8540 x --
- Ask 4.0960 x --
- Day's Range
4.0400 - 4.0960 - 52 Week Range
2.7720 - 12.3900 - Volume
0 - Avg. Volume
50 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.DU
View MorePerformance Overview: T0A.DU
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.DU
8.41%
S&P/TSX Composite index (^GSPTSE)
5.49%
1-Year Return
T0A.DU
65.90%
S&P/TSX Composite index (^GSPTSE)
16.47%
3-Year Return
T0A.DU
70.83%
S&P/TSX Composite index (^GSPTSE)
28.53%
5-Year Return
T0A.DU
81.08%
S&P/TSX Composite index (^GSPTSE)
77.42%
Compare To: T0A.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.0960
+5.19%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5750
+5.29%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6000
-4.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5850
-4.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6050
+7.08%
Mkt Cap EUR 11.759M
Industry Drug Manufacturers—Specialty & Generic
0.0070
0.00%
Mkt Cap EUR 2.503M
Industry Drug Manufacturers—Specialty & Generic
0.2360
0.00%
Mkt Cap EUR 76.786M
Industry Drug Manufacturers—Specialty & Generic
0.0700
0.00%
Mkt Cap EUR 12.693M
Industry Drug Manufacturers—Specialty & Generic
1.1840
+8.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4100
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0850
-3.41%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.DU
View MoreValuation Measures
As of 5/16/2025
Market Cap
759.61M
Enterprise Value
1.20B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.74
Price/Book (mrq)
0.71
Enterprise Value/Revenue
1.13
Enterprise Value/EBITDA
4.90
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--